| 2024-09-06 |
Stat Bite: Cancer of the Corpus and Uterus 5-Year Survival by Race and Ethnicity and Stage |
|
|
| 2024-09-06 |
Reviewers |
|
|
| 2024-09-06 |
Correction to: Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome |
|
|
| 2024-09-06 |
The utility of value frameworks in cost communications: making them real for patients |
|
|
| 2024-09-06 |
Improving our understanding of the complex relationship between cancer-related cognitive decline and Alzheimer’s disease |
|
|
| 2024-09-06 |
RE: Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma? |
|
|
| 2024-09-06 |
RE: Spatial intratumor heterogeneity of programmed cell death ligand 1 expression predicts poor prognosis in resected non–small cell lung cancer |
|
|
| 2024-09-06 |
Response to Wu and Zhang |
|
|
| 2024-09-06 |
Future patterns in burden and incidence of squamous cell carcinoma of the anus in the United States, 2001-2035 |
|
|
| 2024-09-06 |
Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities |
|
|
| 2024-09-06 |
Primary human papillomavirus testing vs cotesting: clinical outcomes in populations with different disease prevalence |
|
|
| 2024-09-06 |
The association of body composition phenotypes before chemotherapy with epithelial ovarian cancer mortality |
|
|
| 2024-09-06 |
Alzheimer disease–related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study |
|
|
| 2024-09-06 |
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208) |
|
|
| 2024-09-06 |
Association between oral targeted cancer drug net health benefit, uptake, and spending |
|
|
| 2024-09-06 |
Health insurance among survivors of childhood cancer following Affordable Care Act implementation |
|
|
| 2024-09-06 |
Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists |
|
|
| 2024-09-06 |
Recent and projected incidence trends and risk of anal cancer among people with HIV in North America |
|
|
| 2024-09-06 |
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study) |
|
|
| 2024-09-06 |
Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease |
|
|
| 2024-08-08 |
Stat Bite: The most frequent five cancers diagnosed worldwide, and the most frequent cancer diagnosed in each of 185 countries among males aged 15-34 years in 2022 |
|
|
| 2024-08-08 |
Correction to: Quality-of-life outcomes in metastatic spinal cord compression: findings from the SCORAD trial |
|
|
| 2024-08-08 |
Correction to: In Vitro and In Vivo Inhibition of Neuroblastoma Tumor Cell Growth by AKT Inhibitor Perifosine |
|
|
| 2024-08-08 |
Editor’s Note to: Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex |
|
|
| 2024-08-08 |
Correction to: Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial |
|
|
| 2024-08-08 |
When the somatic genome informs the germline: the example of TP53 |
|
|
| 2024-08-08 |
RE: Dietary interventions in cancer: a systematic review of all randomized controlled trials |
|
|
| 2024-08-08 |
RE: Association of metformin use and cancer incidence: a systematic review and meta-analysis |
|
|
| 2024-08-08 |
Response to Khouri and Suissa |
|
|
| 2024-08-08 |
Dietary interventions, statistical power, and unanswered questions |
|
|
| 2024-08-08 |
Time to change the paradigm for primary endpoints in cancer screening trials? |
|
|
| 2024-08-08 |
RE: The impact of multidisciplinary cancer conferences on overall survival: a meta-analysis |
|
|
| 2024-08-08 |
Response to Shamsi, Hina, Akhtar, et al. |
|
|
| 2024-08-08 |
Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors |
|
|
| 2024-08-08 |
Executing plans to enhance diversity across cancer centers in the United States: opportunities and challenges |
|
|
| 2024-08-08 |
Identification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalence |
|
|
| 2024-08-08 |
Cancer control co-benefits of the climate-related provisions in the American Inflation Reduction Act |
|
|
| 2024-08-08 |
Prediagnostic plasma proteomics profile for hepatocellular carcinoma |
|
|
| 2024-08-08 |
Expanding active living after cancer to underserved cancer survivors and their caregivers |
|
|
| 2024-08-08 |
Prevalence of anal cytology screening among persons with HIV and lack of access to high-resolution anoscopy at HIV care facilities |
|
|
| 2024-08-08 |
The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review |
|
|
| 2024-08-08 |
Growing the global cancer care system: success stories from around the world and lessons for the future |
|
|
| 2024-08-08 |
The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17 |
|
|
| 2024-08-08 |
Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer |
|
|
| 2024-08-08 |
Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma |
|
|
| 2024-08-08 |
Adolescents and young adults with cancer: the clinical course of COVID-19 infections |
|
|
| 2024-08-08 |
A population-based study of COVID-19 mortality risk in US cancer patients |
|
|
| 2024-08-08 |
Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening |
|
|
| 2024-08-08 |
Evaluating colonoscopy quality by performing provider type |
|
|
| 2024-08-08 |
Housing assistance among patients with cancer: SEER-Medicare US Department of Housing and Urban Development data linkage |
|
|
| 2024-08-08 |
Alcohol and colorectal cancer risk, subclassified by mutational signatures of DNA mismatch repair deficiency |
|
|
| 2024-08-08 |
TP53-associated early breast cancer: new observations from a large cohort |
|
|
| 2024-08-08 |
Response of bilateral Wilms tumor to chemotherapy suggests histologic subtype and guides treatment |
|
|
| 2024-08-08 |
Advancing health equity in cancer survivorship research: National Institutes of Health 2017–2022 portfolio review |
|
|
| 2024-08-08 |
Metformin boosts antitumor immunity and improves prognosis in upfront resected pancreatic cancer: an observational study |
|
|
| 2024-08-08 |
The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis |
|
|
| 2024-07-05 |
Stat Bite: Bone Tumor Incidence in Children, Adolescents, and Young Adults |
|
|
| 2024-07-05 |
Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma? |
|
|
| 2024-07-05 |
Quality-of-life outcomes in metastatic spinal cord compression: findings from the SCORAD trial |
|
|
| 2024-07-05 |
RE: Potential role of cannabis in ameliorating observed racialized disparities in cancer pain management |
|
|
| 2024-07-05 |
Measures of physical function clarify the prognostic blur of cancer survivorship |
|
|
| 2024-07-05 |
Targeting fusion oncoproteins in childhood cancers: challenges and future opportunities for developing therapeutics |
|
|
| 2024-07-05 |
Eradicating gross tumor disease: a prerequisite for efficient radioimmunotherapy? |
|
|
| 2024-07-05 |
Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemia |
|
|
| 2024-07-05 |
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysis |
|
|
| 2024-07-05 |
Potential role of cannabis in ameliorating observed racialized disparities in cancer pain management |
|
|
| 2024-07-05 |
Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non–small cell lung cancer |
|
|
| 2024-07-05 |
Randomized trials of multicancer screening tests: augmenting their ability to identify a genuine mortality benefit |
|
|
| 2024-07-05 |
Low physical function following cancer diagnosis is associated with higher mortality risk in postmenopausal women |
|
|
| 2024-07-05 |
Effects of a change in recall period on reporting severe symptoms: an analysis of a pragmatic multisite trial |
|
|
| 2024-07-05 |
Health-related quality of life and DNA methylation-based aging biomarkers among survivors of childhood cancer |
|
|
| 2024-07-05 |
Increasing radiation therapy and lower survival for human papillomavirus–related oropharynx cancer associated with a shift to community cancer center care |
|
|
| 2024-07-05 |
Population-level incidence of human papillomavirus–positive oropharyngeal, cervical, and anal cancers, by smoking status |
|
|
| 2024-07-05 |
Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk |
|
|
| 2024-07-05 |
Dietary interventions in cancer: a systematic review of all randomized controlled trials |
|
|
| 2024-07-05 |
Assessing racial, ethnic, and nativity disparities in US cancer mortality using a new integrated platform |
|
|
| 2024-07-05 |
COVID-19 vaccination, infection, and symptoms among cancer survivors in the United States |
|
|
| 2024-07-05 |
Multi-tissue transcriptome-wide association studies identified 235 genes for intrinsic subtypes of breast cancer |
|
|
| 2024-07-05 |
Association between diet quality and ovarian cancer risk and survival |
|
|
| 2024-07-05 |
Use of cancer-directed therapy at the end of life among adolescents and young adults |
|
|
| 2024-07-05 |
Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020 |
|
|
| 2024-07-05 |
Effect of surgery versus chemotherapy in pancreatic cancer patients: a target trial emulation |
|
|
| 2024-06-08 |
Estimated cumulative risk of female breast cancer incidence and mortality (ages 0-74) in 2022 |
|
|
| 2024-06-08 |
Correction to: Tamoxifen for the Prevention of Breast Cancer: Late Results of the Italian Randomized Tamoxifen Prevention Trial Among Women With Hysterectomy |
|
|
| 2024-06-08 |
Correction to: Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study |
|
|
| 2024-06-08 |
The complexities of PM2.5, greenspace, and childhood cancer |
|
|
| 2024-06-08 |
Clinic-based interventions for improving access to care: a good start |
|
|
| 2024-06-08 |
Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer |
|
|
| 2024-06-08 |
A new perspective on mitigating lung cancer risks through smoking cessation and reduction |
|
|
| 2024-06-08 |
Familial adversity: association with discontinuation of adjuvant hormone therapy and breast cancer prognosis |
|
|
| 2024-06-08 |
Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome |
|
|
| 2024-06-08 |
Predicting five-year interval second breast cancer risk in women with prior breast cancer |
|
|
| 2024-06-08 |
Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study |
|
|
| 2024-06-08 |
An orientation to the US National Cancer plan for the research community |
|
|
| 2024-06-08 |
Prediagnostic evaluation of multicancer detection tests: design and analysis considerations |
|
|
| 2024-06-08 |
Health-care organization characteristics in cancer care delivery: an integrated conceptual framework with content validation |
|
|
| 2024-06-08 |
Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study |
|
|
| 2024-06-08 |
PM2.5, vegetation density, and childhood cancer: a case-control registry-based study from Texas 1995-2011 |
|
|
| 2024-06-08 |
Palliative prognostic scores for survival prediction of cancer patients: a systematic review and meta-analysis |
|
|
| 2024-06-08 |
Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer |
|
|
